Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation

por Fouladi, Fariba, Jehn, Lutz B., Metzelder, Stephan K., Hub, Florian, Henkenius, Katharina, Burchert, Andreas, Brendel, Cornelia, Stiewe, Thorsten, Neubauer, Andreas
Publicado 2015

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

por Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, S K, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H, Ottmann, O G
Publicado 2017